Table 1

BMI, height, and prostate cancer; results from available studies

StudyStudy size/age at entry or birth cohortBMIRR (95% CI)Height (inches)RR (95% CI)
Cohort studies: incidence
 Severson et al., Hawaii (Japanese men)174 prostate cancer cases<22.491.00Leg length
  1988a (36) (1990–1919)22.50–24.991.23 (0.85–1.79)0–29.11.00
≥25.001.33 (0.92–1.92)29.2–30.31.41 (0.98–2.04)
>30.31.24 (0.86–1.79)
 Thompson et al., Rancho Bernardo, United States of America 1989 (29)54 prostate cancer cases, age 50–84BMI/2.92 kg/m21.1 (0.9–1.4)
 Mills et al., Seventh Day, 1989 (30)180 prostate cancer cases≤23.21.00
 (born before 1949)23.3–25.80.98 (0.67–1.44)
≥25.81.17 (0.79–1.72)
 LeMarchand et al., Hawaii 1994a (31)198 prostate cancer cases,<221.00<63.81.00
 age 45+22–240.8 (0.6–1.2)63.9–65.71.1 (0.6–1.8)
24–260.9 (0.6–1.3)65.8–68.11.8 (1.2–2.9)
>260.7 (0.5–1.2)>68.11.8 (1.0–3.2)
 Thune et al., Norway, 1994 (54)Age 19–54BMI/unit1.25 (1.05–1.50)Height/every 3.94 inches0.99 (0.82–1.19)
 Gronberg et al., Sweden 1996 (55)406 prostate cancer cases<231.00
 (1886–1925)23–25.991.14
26–28.991.44
≥291.80
 Herbert et al., United States of America1047 prostate cancer cases≤671.00
  1996 (49) (1900–1944), age 40–8468–691.23 (1.00–1.51)
70–711.26 (1.04–1.54)
721.59 (1.27–1.98)
≥731.27 (1.01–1.59)
 Andersson et al., Swedish 1997a (37)2368 prostate cancer cases,<22.11.00<67.71.00
age 20+22.1–24.11.09 (0.94–1.26)67.7–69.71.05 (0.95–1.16)
24.2–26.21.10 (0.96–1.26)69.8–70.91.07 (0.96–1.21)
>26.21.13 (0.99–1.29)>70.91.14 (1.00–1.29)
 Cerhan et al., Iowa rural, 1997a (38)69 prostate cancer cases,<23.61.00<68.11.00
 age 65–10123.6–25.80.9 (0.5–1.9)68.1–69.70.8 (0.4–1.4)
25.9–27.81.2 (0.6–2.5)69.8–70.90.6 (0.3–1.2)
>27.81.7 (0.8–3.3)>70.91.1 (0.6–2.0)
17 regional distant prostate<23.61.00
 cancer cases23.6–25.81.6 (0.3–7.4)
25.9–27.82.8 (0.6–13)
>27.83.1 (0.7–14)
 Giovannucci et al., United States of1369 prostate cancer cases;<231.00≤681.00
  America 1997 (28) (1911–1946), age 40–7523–23.91.25 (1.03–1.51)691.09 (0.91–1.30)
24–24.91.20 (0.98–1.46)701.07 (0.91–1.27)
25–25.91.05 (0.87–1.28)711.08 (0.90–1.30)
26–26.90.94 (0.74–1.18)720.98 (0.80–1.19)
27–28.91.11 (0.90–1.36)731.22 (0.97–1.55)
≥290.90 (0.71–1.15)≥741.37 (1.10–1.70)
407 advanced cases<231.00≤681.00
23–23.91.23 (0.88–1.72)691.14 (0.81–1.59)
24–24.91.18 (0.83–1.68)701.06 (0.77–1.45)
25–25.91.01 (0.71–1.43)711.29 (0.93–1.79)
26–26.90.89 (0.58–1.36)721.11 (0.78–1.58)
27–28.91.22 (0.85–1.76)731.63 (1.10–2.41)
≥291.19 (0.79–1.82)≥741.68 (1.16–2.43)
 Schuurman, A.G. et al., Netherlands681 prostate cancer cases<221.00<66.91.00
  1999a (41) (1917–1931), age 55–6922–241.20 (0.84–1.73)66.9–68.90.90 (0.65–1.24)
24–261.35 (0.95–1.90)69.0–70.91.08 (0.79–1.47)
26–281.26 (0.87–1.83)71.0–72.80.98 (0.70–1.37)
>280.89 (0.58–1.37)72.9–74.80.78 (0.51–1.19)
>74.80.96 (0.52–1.75)